TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
183,460
|
157,133
|
139,658 |
| Financial expenses |
563
|
594
|
285 |
| Earnings before taxes |
7,857
|
6,334
|
2,829 |
| Total assets |
61,832
|
50,227
|
45,605 |
| Current assets |
49,875
|
39,722
|
34,091 |
| Current liabilities |
14,735
|
10,907
|
11,147 |
| Equity capital |
34,647
|
28,488
|
23,515 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) | 41 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.0%
|
56.7%
|
51.6% |
| Turnover per employee | 3,406 | ||
| Profit as a percentage of turnover |
4.3%
|
4.0%
|
2.0% |
| Return on assets (ROA) |
13.6%
|
13.8%
|
6.8% |
| Current ratio |
338.5%
|
364.2%
|
305.8% |
| Return on equity (ROE) |
22.7%
|
22.2%
|
12.0% |
| Change turnover |
26,327
|
17,475
|
-22,270 |
| Change turnover % |
17%
|
13%
|
-14% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.